# OnCo record nct06600789 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06600789/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06600789", "NCT06600789" ;
  schema:name "A Modular Phase 1/2 Study With CT7439 in Participants With Solid Malignancies"@en ;
  schema:description "A phase 1/2 trial of CT7439 Capsules (0.5 mg, 1mg, 3mg, 10mg, 15mg, 20mg) in advanced solid tumours, run by Carrick Therapeutics Limited, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06600789/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06600789> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2024-08-16" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> .